Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 16/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31423124 | 1.00 | AR (0.63) | ARCYP1A2CYP2C19TNKS2KDM4E | |
| SCHEMBL15828556 | 0.81 | CYP1A2 (0.61) | ARCYP1A2CYP2C19TNKS2KDM4E | |
| SCHEMBL1771872 | 0.80 | AR (0.61) | ARTNKS2 | |
| SCHEMBL14969318 | 0.80 | AR (0.49) | AR | |
| SCHEMBL1771008 | 0.79 | AR (0.69) | AR | |
| SCHEMBL1771152 | 0.79 | AR (0.69) | AR | |
| SCHEMBL13429043 | 0.78 | KIF11 (0.45) | ARCYP1A2CYP2C19TNKS2KDM4E | |
| SCHEMBL30946245 | 0.78 | KIF11 (0.51) | ARKDM4EALDH1A1HPGDHTT | |
| SCHEMBL3787127 | 0.78 | KIF11 (0.51) | ARKDM4EALDH1A1HPGDHTT | |
| SCHEMBL31331602 | 0.77 | AR (1.00) | AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1181341-B1 | LUMINESCENT 4-TRIFLUOROMETHYL-2-QUINOLONES WITH LONG-WAVE UV-ABSORPTION AND THE USE THEREOF | URAY GEORG (AT) | 2004-10-27 | — | — | EP | claimed |
| EP-0931065-B1 | use of NITRIC ESTER DERIVATIVES IN the treatment of URINARY INCONTINENCE | NICOX SA (FR) | 2004-07-28 | — | — | EP | claimed |
| US-6635759-B2 | Used as luminescent marker for peptides, proteins, RNA and DNA, as complexing agent | Uray, Georg (AT) | 2003-10-21 | — | — | US | claimed |
| US-20020058793-A1 | Luminescent 4-trifluoromethy1-2-quinolones with long wave UV absorption and their use | AGILENT TECHNOLOGIES, INC. | 2002-05-16 | — | — | US | claimed |
| EP-1181341-A2 | LUMINESCENT 4-TRIFLUOROMETHYL-2-QUINOLONES WITH LONG-WAVE UV-ABSORPTION AND THE USE THEREOF | Uray, Georg (AT) | 2002-02-27 | — | — | EP | claimed |
| WO-2000066680-A2 | LUMINESCENT 4-TRIFLUOROMETHYL-2-QUINOLONES WITH LONG-WAVE UV-ABSORPTION AND THE USE THEREOF | URAY GEORG (AT) | 2000-11-09 | — | — | WO | claimed |
| WO-2024085525-A1 | IRIDIUM COMPLEX, PHOTOSENSITIZER, AND COMPOSITION FOR PHOTODYNAMIC THERAPY | 울산과학기술원 | 2024-04-25 | — | — | WO | disclosed |
| US-20230158005-A1 | Substituted Azole Dione Compounds with Antiviral Activity | STEMLINE THERAPEUTICS, INC. (US) | 2023-05-25 | — | — | US | disclosed |
| US-11248007-B2 | Inhibitors of MALT1 and uses thereof | CORNELL UNIVERSITY (US) | 2022-02-15 | — | — | US | disclosed |
| US-11248007-B2 | Inhibitors of MALT1 and uses thereof | CORNELL UNIVERSITY (US) | 2022-02-15 | — | — | US | disclosed |
| WO-2021194954-A1 | SUBSTITUTED AZOLE DIONE COMPOUNDS WITH ANTIVIRAL ACTIVITY | STEMLINE THERAPEUTICS, INC. (US) | 2021-09-30 | — | — | WO | disclosed |
| US-20200385405-A1 | INHIBITORS OF MALT1 AND USES THEREOF | CORNELL UNIVERSITY (US) | 2020-12-10 | — | — | US | disclosed |
| US-20200385405-A1 | INHIBITORS OF MALT1 AND USES THEREOF | CORNELL UNIVERSITY (US) | 2020-12-10 | — | — | US | disclosed |
| US-20020058793-A1 | Luminescent 4-trifluoromethy1-2-quinolones with long wave UV absorption and their use | AGILENT TECHNOLOGIES, INC. | 2002-05-16 | — | — | US | disclosed |
| US-20020058793-A1 | Luminescent 4-trifluoromethy1-2-quinolones with long wave UV absorption and their use | AGILENT TECHNOLOGIES, INC. | 2002-05-16 | — | — | US | disclosed |
| EP-1181341-A2 | LUMINESCENT 4-TRIFLUOROMETHYL-2-QUINOLONES WITH LONG-WAVE UV-ABSORPTION AND THE USE THEREOF | Uray, Georg (AT) | 2002-02-27 | — | — | EP | disclosed |
| EP-1181341-A2 | LUMINESCENT 4-TRIFLUOROMETHYL-2-QUINOLONES WITH LONG-WAVE UV-ABSORPTION AND THE USE THEREOF | Uray, Georg (AT) | 2002-02-27 | — | — | EP | disclosed |
| WO-2000066680-A3 | LUMINESCENT 4-TRIFLUOROMETHYL-2-QUINOLONES WITH LONG-WAVE UV-ABSORPTION AND THE USE THEREOF | URAY GEORG (AT) | 2001-04-12 | — | — | WO | disclosed |
| WO-2000066680-A2 | LUMINESCENT 4-TRIFLUOROMETHYL-2-QUINOLONES WITH LONG-WAVE UV-ABSORPTION AND THE USE THEREOF | URAY GEORG (AT) | 2000-11-09 | — | — | WO | disclosed |
| WO-2000066680-A2 | LUMINESCENT 4-TRIFLUOROMETHYL-2-QUINOLONES WITH LONG-WAVE UV-ABSORPTION AND THE USE THEREOF | URAY GEORG (AT) | 2000-11-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200385405-A1 | INHIBITORS OF MALT1 AND USES THEREOF | MALT1, BCL6, BCL3 | AR 3939/4885CYP1A2 4025/4885CYP2C19 4491/4885 |
| US-11248007-B2 | Inhibitors of MALT1 and uses thereof | MALT1, BCL6, BCL3 | AR 3939/4885CYP1A2 4025/4885CYP2C19 4491/4885 |
| US-20020058793-A1 | Luminescent 4-trifluoromethy1-2-quinolones with long wave UV absorption and their use | CYP4F2, CYP4F12, CRY1 | AR 4741/4885CYP1A2 85/4885CYP2C19 68/4885 |
| US-20230158005-A1 | Substituted Azole Dione Compounds with Antiviral Activity | MAVS, DDX18, ZC3HAV1 | AR 2958/4885CYP1A2 655/4885CYP2C19 1656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.